The move to include Covaxin even before the publication of data from its phase 3 trial had come under criticism from some quarters.   However, the regulator had defended the decision by saying that both the vaccines were totally safe.   Over 500 adverse reactions were reported from across the country during two days of … Continue reading BharatBiotech says Covaxin is to be administered subject to Conditions apply clauses